Готові списки джерел за темами / Pre-exposure prophylaxy

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Pre-exposure prophylaxy"

Автор: Grafiati
Опубліковано: 20 квітня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Pre-exposure prophylaxy".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Pre-exposure prophylaxy"

1

Hull, M., and DHS Tan. "Préparer le terrain pour l’élargissement de l’utilisation de la prophylaxie préexposition contre le VIH au Canada." Relevé des maladies transmissibles au Canada 43, no. 12 (December 7, 2017): 310–17. http://dx.doi.org/10.14745/ccdr.v43i12a05f.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Jesus, Déberson Ferreira de, Glória Luiza Silveira da Silva, and Neuza Cristina Gomes da Costa. "PERCEPÇÃO DE PSICÓLOGOS SOBRE A PROFILAXIA PRÉ-EXPOSIÇÃO AO HIV (PREP) EM MATO GROSSO." Psicologia e Saúde em Debate 9, no. 2 (September 15, 2023): 336–54. http://dx.doi.org/10.22289/2446-922x.v9n2a19.

Повний текст джерела
Анотація:
HIV Pre-Exposure Prophylaxis (PrEP) is a public health strategy to reduce the probability of HIV acquisition by people at high risk of exposure. This paper addresses the perception of psychologists in the primary health care public system about the PrEP policy in the state of Mato Grosso, Brazil. Through semi-structured interviews, we sought to understand the therapeutic itinerary in the unit where it takes, as well as the opinions and involvement of the psychologists in the implementation of PrEP. There is a lack of definition regarding the attributions and scope of action of the psychologist in relation to PrEP in health units. In some, reception is mandatory in the first service, in others only if there is a request from the user. The interviews revealed that there are distrust and prejudice in relation to the policy and users' social behaviour, as well as the recognition of the lack of training and dissemination as the primary motivations for the low adherence. Psychologists proved to be important professionals in implementing PrEP. Notwithstanding, more dialogue is needed with management at the local and state level so that doubts, beliefs, and social representations are discussed and do not compromise the effectiveness of the policy.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Popovic, Nashira, Qiuying Yang, and Chris Archibald. "Tendances d’utilisation de la prophylaxie pré-exposition pour le VIH dans huit provinces canadiennes, 2014 à 2018." Relevé des maladies transmissibles au Canada 47, no. 56 (June 9, 2021): 275–83. http://dx.doi.org/10.14745/ccdr.v47i56a02f.

Повний текст джерела
Анотація:
Contexte : Le Canada a approuvé les objectifs mondiaux du Programme commun des Nations Unies sur le VIH et le Sida visant à mettre fin à l’épidémie du syndrome d’immunodéficience acquise (sida), notamment en réduisant à zéro les nouvelles infections par le virus de l’immunodéficience humaine (VIH) d’ici à 2030. Compte tenu de l’efficacité de la prophylaxie pré-exposition (PPrE) pour prévenir les nouvelles infections, il est important de mesurer et de rendre compte de l’utilisation de la PPrE afin de contribuer à la planification des programmes et des politiques de prévention du VIH. Méthodes : Les estimations annuelles des personnes utilisant de la PPrE au Canada ont été générées pour la période de 2014 à 2018 à partir de l’ensemble de données géographiques de surveillance des ordonnances d’IQVIA. On a utilisé un algorithme pour distinguer les utilisateurs de fumarate de ténofovir disoproxil/emtricitabine (TDF/FTC) pour la PPrE de ceux qui l’utilisent dans le cadre d’un traitement ou de la prophylaxie post-exposition. Nous fournissons le nombre estimé de personnes qui utilisent la PPrE dans huit provinces canadiennes par sexe, groupe d’âge, spécialité du médecin prescripteur et type de paiement. Résultats : Le nombre estimé d’utilisateurs de PPrE a augmenté de façon spectaculaire au cours de la période d’étude de cinq ans : il est multiplié par 21, passant de 460 en 2014 à 9 657 en 2018. La prévalence estimée de la PPrE était de 416 utilisateurs par million de personnes dans les huit provinces en 2018. Presque tous les utilisateurs de PPrE étaient des hommes. L’utilisation a augmenté chez les deux sexes, mais l’augmentation a été plus importante chez les hommes (par 23 fois) que chez les femmes (par 5 fois). L’utilisation a augmenté dans toutes les provinces, bien qu’il y ait des différences entre les provinces relativement à la prévalence de l’utilisation, à la répartition par âge et aux types de médecins prescripteurs. Conclusion : L’utilisation de la PPrE au Canada a augmenté entre 2014 et 2018, ce qui témoigne d’une meilleure connaissance et d’une plus grande adhésion à son utilisation pour prévenir la transmission du VIH. Elle est toutefois inégale en fonction de l’âge, du sexe et de la géographie. Puisque les nouvelles infections au VIH continuent de se produire au Canada, il sera important d’affiner l’utilisation de la PPrE, car les populations à risque plus élevé d’infection au VIH doivent se voir offrir la PPrE dans le cadre de soins de santé sexuelle complets.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Shewale, Ajit. "A Case for Pre-Exposure Prophylaxis of High-Risk Groups against Rabies in India." Journal of Communicable Diseases 53, no. 01 (March 31, 2021): 110–16. http://dx.doi.org/10.24321/0019.5138.202118.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Ng, Yeow Chye, and Jack J. Mayeux. "Initiating pre-exposure prophylaxis." Nurse Practitioner 46, no. 8 (August 2021): 17–22. http://dx.doi.org/10.1097/01.npr.0000757076.21006.50.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Singh, AjaiKumar, Ashish Singh, Deepti Singh, Manish Singh, Pratibha Singh, and Abhishek Sharma. "HIV: Pre-exposure prophylaxis." International Journal of Preventive Medicine 3, no. 12 (2012): 900. http://dx.doi.org/10.4103/2008-7802.104864.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Morin, S. F., G. Yamey, and G. W. Rutherford. "HIV pre-exposure prophylaxis." BMJ 345, aug13 1 (August 13, 2012): e5412-e5412. http://dx.doi.org/10.1136/bmj.e5412.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sharma, Malika, and Darrell H. S. Tan. "HIV pre-exposure prophylaxis." Canadian Medical Association Journal 186, no. 15 (August 5, 2014): E588. http://dx.doi.org/10.1503/cmaj.140127.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Wille, Lexie, and Mike C. Parent. "Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake." AIDS Patient Care and STDs 34, no. 12 (December 1, 2020): 499–501. http://dx.doi.org/10.1089/apc.2020.0196.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Atim, M., N. Girometti, I. Hyndman, A. McOwan, G. Whitlock, Keerti Gedela, Sheena McCormack, et al. "Post‐exposure prophylaxis in the era of pre‐exposure prophylaxis." HIV Medicine 21, no. 10 (September 9, 2020): 668–70. http://dx.doi.org/10.1111/hiv.12917.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Pre-exposure prophylaxy"

1

Luong, Nguyen Liêm Binh. "Modélisation et analyse en coût-efficacité des stratégies de prévention, de dépistage et de traitement de l'infection par le VIH à Ndhiwa, Kenya." Electronic Thesis or Diss., Université Paris Cité, 2021. http://www.theses.fr/2021UNIP5233.

Повний текст джерела
Анотація:
Médecin Sans Frontière (MSF) intervient depuis les années 1980 à Ndhiwa, un sous-comté du Sud-Ouest du Kenya, où sévit une épidémie généralisée de VIH, avec une prévalence à 24% et une incidence à 2,2/100 personnes année (PA). Conformément aux objectifs de l’ONUSIDA 90-90-90, puis 95-95-95, MSF a décidé de mettre en place différentes interventions pour diminuer l’incidence de l’infection par le VIH. Dans un premier temps, nous avons développé un modèle mathématique de la transmission et de l’histoire naturelle de l’infection par le VIH à Ndhiwa afin d’étudier l’efficacité et le coût efficacité de trois niveaux d’interventions sur le continuum de soin. Nous avons ainsi estimé qu’en maintenant l’offre de soins à son niveau actuel, sans intervention, l’incidence de l’infection par le VIH diminuerait à 1,51/100 PA en 2032, tandis que seules les interventions de rétention et la combinaison de toutes les stratégies faisaient baisser l’incidence respectivement à 1,03/100 PA et 0,75/100 PA. Comparé au standard de soins, la stratégie de rétention avait un rapport incrémental de coût-efficacité de 130€/année de vie gagnée (AVG) tandis que La combinaison des interventions atteint un ICER de 370€/AVG. Dans un deuxième temps, nous avons modélisé l’efficacité d’une intervention qui améliorerait le continuum de soin de 90-90-90 à 95-95-95, comparée à une intervention qui implémenterait une prophylaxie pré-exposition (PrEP) sur une population à haut risque avec un taux de couverture de 10%. Nous estimons que dans une épidémie généralisée où le continuum de soin atteint 90-90-90, l’amélioration du continuum de soin à 95-95-95 est plus efficace que la PrEP pour diminuer l’incidence de l’infection par le VIH En conclusion, les résultats de notre travail soulignent les effets synergiques e très coût-efficace d’interventions multimodales sur le continuum de soin, et leur rôle important aussi important que la PrEP pour diminuer l’incidence de l’infection par le VIH
Médecin Sans Frontière (MSF) have been working since the early 1980’s on HIV care delivery in Ndhiwa, a rural sub-county in Southwest Kenya. This area suffers from a generalized HIV epidemic, with 24% prevalence and 2.2/100 person years (PY) incidence. In line with the UNAIDS 90-90-90 and 95-95-95 targets, MSF has implemented interventions to decrease HIV incidence. In the first part of this work, we have developped a mathematical model of HIV natural history and transmission in Ndhiwa to evaluate the effectiveness and cost-effectiveness of three different interventions on HIV continuum of care. We estimated than current standard of care would decrease HIV incidence to 1.51/100 PY in 2032, whereas only retention intervention and combined interventions would further decrease HIV incidence to 1.03/100 PY and 0,75/100 PY, respectively. Compared to standard of care, retention to care intervention has an incremental cost-effectiveness ratio (ICER) of 130€/years of live saved (YLS) whereas combined intervention has an ICER of 370€/YLS. In the second part, we modeled the effectiveness of the improvement of continuum of care from 90-90-90 to 95-95-95, compared with a Pre-exposure Prophylaxis (PrEP) intervention with 10% coverage in high-risk group. We found that in the context of generalized epidemic where continuum of care reach 90-90-90, an improvement to 95-95-95 would be more effective than PrEP to decrease incidence. To conclude, combined interventions on HIV continuum of care have synergic effects and are very cost-effective. We also underlined the importance of maintaining a high level continuum of care to decrease HIV incidence, which is as important as PrEP to fight the HIV pandemic
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Kokolo, Madzouka B. "HIV oral pre-exposure prophylaxis (PrEP) trials: A systematic review and systematic ethics appraisal." Thesis, University of Ottawa (Canada), 2010. http://hdl.handle.net/10393/28681.

Повний текст джерела
Анотація:
BACKGROUND. Pre-exposure prophylaxis (PrEP) is an experimental HIV prevention approach whereby antiretroviral pills are used before anticipated exposure. It is unclear how ethical considerations have been addressed by investigators. METHODS. A systematic review of PrEP controlled prospective studies was conducted. Pre-determined data items were extracted from registries, protocols, reports, and consent forms. Study characteristics, methods, and ethics considerations were synthesized. RESULTS. Among sixteen studies included, twelve involved resource-limited countries. Quality scores were generally high and overall risk of bias was low. Considerations for social value were the least reported whereas considerations for the fair selection of study population were the most reported. More ethics considerations tend to be reported with time. No meta-analysis was performed, as few data were available. CONCLUSION. As critical as clinical data generation is for scientific progress, ethics should be monitored and adequately reported, lest lack of consideration for key principles be uncovered after the facts.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Terry-Smith, Justin B. "Factors Influencing Use of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men." Thesis, Walden University, 2018. http://pqdtopen.proquest.com/#viewpdf?dispub=10816883.

Повний текст джерела
Анотація:

Prevention is key to keeping men who have sex with men (MSM) protected from Human Immunodeficiency Virus (HIV). Despite new and innovative HIV prevention resources such as pre-exposure prophylaxis (PrEP), factors such as education level, employment status, number of sexual partners, and access to health resources may inhibit certain populations from using PrEP. The purpose of this cross-sectional study was to examine the association between education level, employment status, number of sexual partners, and access to health resources and the use of PrEP among MSM. The fundamental cause theory was used to examine how socioeconomic barriers are associated with the use of PrEP among MSM in the United States. Secondary data from 217 surveys were collected from the Public Library of Science. Findings from multiple regression analyses indicated that employment status, access to health resources, and number of sexual partners were not associated with use of PrEP among MSM. Those who had at least some high school or a high school diploma were 3.98 times more likely to be likely to extremely likely to use PrEP, compared to those who had less than a high school education (OR = 3.98, p = .048). Those who had some college were 6.91 more likely to be likely to extremely likely to use PrEP, compared to those who had less than a high school education (OR = 6.91, p = .028). Findings may be used to assist public health professionals in identifying factors that prevent the use of PrEP. By addressing these health threats, and social barriers, specialists could have the ability to increase HIV prevention activity in populations that are more susceptible to being infected with HIV and may decrease HIV infections not only within the MSM population but also in other populations.

Стилі APA, Harvard, Vancouver, ISO та ін.
4

Nutland, W. "The acceptability of pre-exposure HIV prophylaxis in men who have sex with men in London." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2016. http://researchonline.lshtm.ac.uk/2837729/.

Повний текст джерела
Анотація:
Men who have sex with men (MSM) remain the group with the highest incidence of HIV in the UK, with a high concentration of infections in London. Multi-site safety and efficacy trials have demonstrated significant reductions in HIV acquisition among MSM when prescribed a daily pre-exposure prophylaxis (PrEP). Success translating these scientific developments into effective prevention interventions requires an understanding of how acceptable they are to individuals at risk of HIV acquisition. This thesis reports on the findings of twenty in-depth semi-structured qualitative interviews with MSM in London. To participate, men must have had at least one episode of sex without condoms with a known sero-discordant partner or a partner of unknown HIV status in the twelve months prior to interview. The acceptability of a range of PrEP methods were explored, including daily and intermittent oral; topical; and injectable formulations of PrEP and the potential impact of PrEP use upon men’s perceptions of risk and behaviours. Dimensions of acceptability draw on the personal (such as side effects; increased or diminished HIV vulnerability; adherence to drug/medical regimes); the inter-personal (such as negotiation of sex; stigma or discrimination); and community or social concepts of acceptability (such as financial burden and concepts of increased ‘community risk’). The thesis provides a framework for understanding PrEP acceptability, showing that concepts of acceptability are complex and that the different dimensions of acceptability are inter-related. The thesis concludes with recommendations for future policy and service delivery of PrEP to at-risk groups in the UK.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Schexnayder, Julie Kay. "Disparities in HIV Pre-Exposure Prophylaxis Implementation for Black and Latinx Adults Receiving Care in Public Health Clinics." Case Western Reserve University School of Graduate Studies / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=case160709474635545.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Blair, Kevin J., Eddy R. Segura, Alex Garner, Jianchao Lai, Amy Ritterbusch, Sebastian Leon-Giraldo, Vincent Guilamo-Ramos, Jordan E. Lake, Jesse Clark, and Ian W. Holloway. "PrEP Awareness, Use, Intention to Use, and Information Source Among Geosocial Networking Application Users in Mexico in 2018–2019." Springer, 2021. http://hdl.handle.net/10757/655887.

Повний текст джерела
Анотація:
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.
Pre-exposure prophylaxis (PrEP) has limited availability across Latin America, though access is increasing. We explored PrEP uptake in Mexico via an online survey completed by Spanish-speaking, Hornet geosocial networking application (GSN app) users without HIV (n = 2020). Most (81.3%) had heard of PrEP, 3.5% were current users, and 34.2% intended to take PrEP within six months. Current PrEP use was associated with PrEP eligibility (aOR 26.07 [95%CI 13.05–52.09], p < 0.001), recent STI testing (aOR 3.79 [95%CI 1.10–13.11], p = 0.035), and recent chemsex (aOR 3.02 [95%CI 1.02–8.93], p = 0.046). Recent STI testing was associated with hearing about PrEP from a doctor (aOR 3.26 [95%CI 1.98–5.36], p < 0.001), and those who lived in large cities were less likely to have learned about PrEP via Hornet (aOR 0.52 [95%CI 0.32–0.85], p = 0.009). Interventions to increase PrEP uptake in Mexico should build upon existing health networks and utilize GSN apps for PrEP information dissemination, particularly in less populated areas.
University of California
Revisión por pares
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Umboh, Lucyan Fransisca. "Awareness, Knowledge and Willingness to use HIV Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender People in Bali, Indonesia." Thesis, The University of Sydney, 2018. http://hdl.handle.net/2123/19468.

Повний текст джерела
Анотація:
Background: World Health Organisation in 2014 has recommended Pre-Exposure Prophylaxis (PrEP) as HIV prevention tool for men who have sex with men (MSM) along with other prevention strategies. Before PrEP implementation is introduced in Indonesia, it is vitally important to have an evidence base about the awareness, knowledge and acceptability among MSM and transgender people and the differences in knowledge and PrEP acceptability based on sexual risk factors of MSM and transgender people. Methods: A cross-sectional study was conducted between July and November 2017 in an MSM clinic in Denpasar, Bali, Indonesia. Eligible participants were men who identified as MSM or transgender, above 18 years old, who had anal sex (receptive or insertive) within the last six months and HIV status known to be negative. Data were collected anonymously via a self-completed questionnaire using a tablet. The key outcomes were exploring the awareness, knowledge and willingness to use PrEP among MSM and transgender people in Bali, Indonesia and determining demographic and sexual risk factors associated with knowledge and willingness to use PrEP. Results: A total of 164 participants were recruited into the study but only 124 participants were eligible and were included in the analysis. Of these, 69 out of 124 (55.6%) participants had never heard about PrEP and the mean scores were low in both high-risk and low–risk groups (28.4, 19.1, respectively). Among those 55 (44.4%) participants who had heard about PrEP, education and occupation were the only factors associated with PrEP knowledge. Men with the University education showed higher knowledge scores (29.2) and were more likely to use PrEP compared with men with lower education levels. 73 out of 124 participants (58.9%) were willing to take PrEP in the future and education was the only factor associated with PrEP willingness. Conclusion: This is the first study to report data on awareness, knowledge and willingness to use PrEP in Bali and is only the second such study conducted in Indonesia. Consistent with similar studies in other countries, this study found limited knowledge of PrEP among MSM and transgender participants. As PrEP is not yet publicly available in Indonesia, it is crucially important to prepare the community by education and disseminating accurate information.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Alves, Clélia Carolina. "Dinâmica do título de anticorpos IgG anti-vírus da raiva na resposta à profilaxia pré-exposição /." Araçatuba, 2019. http://hdl.handle.net/11449/180586.

Повний текст джерела
Анотація:
Orientador: Cáris Maroni Nunes
Coorientador: Luzia Helena Queiroz
Banca: Adolorata Aparecida Bianco Carvalho
Banca: Rafael Silva Cipriano
Resumo: A raiva é uma zoonose globalmente distribuída que apresenta alta letalidade, constituindo grande problema em saúde pública. A persistência do vírus da raiva nas populações é mantida devido sua capacidade de se replicar em diversas espécies de mamíferos, incluindo os humanos. O controle da raiva urbana tem se baseado na vacinação de cães e gatos, reservatórios importantes no ciclo urbano, bem como no atendimento de indivíduos após exposição ao vírus da raiva. Adicionalmente, a profilaxia pré-exposição (PrPE) tem sido aplicada em indivíduos que podem ser expostos à infecção, por atividade ocupacional. Objetivando proteger os estudantes ingressantes do Curso de Medicina Veterinária, grupo de risco em potencial para a raiva, a Faculdade de Medicina Veterinária (FMVA) da Unesp, Câmpus Araçatuba, promove anualmente a vacinação em esquema PrPE, seguida de avaliação sorológica, a fim de habituá-los a anualmente verificarem a resposta de anticorpos. Assim, a presente pesquisa teve como objetivo avaliar, por meio de levantamento de dados de PrPE dos arquivos do Serviço de Vigilância Epidemiológica da Secretaria de Saúde da Prefeitura Municipal de Araçatuba, SP, Brasil a adesão à PrPE, a proteção conferida e a dinâmica dos anticorpos (IgG) neutralizantes contra o vírus da raiva, nos estudantes da FMVA durante o período de 2000 a 2017. Foram avaliados 2.404 registros, 86,4% dos quais apresentaram título protetor contra o vírus da raiva (≥0,5UI/mL). A PrPE teve boa adesão pelos estudantes... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: Rabies is a globally distributed zoonosis that shows high lethality and is also a major public health problem. Persistence of rabies virus in populations is maintained due to its ability to replicate in several mammals species, including humans. Rabies control has been based on dogs and cats' vaccination, the most important reservoirs in the urban cycle, as well as on the treatment of individuals after exposure to the rabies virus. In addition, pre-exposure prophylaxis (PEPr) has been applied in individuals who might be exposed to infection due to their occupational activities. In order to protect the incoming students of the veterinary medicine course, a group of potential risk for rabies, the School of Veterinary Medicine (FMVA) of Unesp, Araçatuba, SP, Brazil, promotes annual vaccination in a PEPr scheme, followed by a serological evaluation, in order to habituate them to annually check their antibody response. Thus, by analyzing the PEPr data from the archives of the Epidemiological Surveillance Service of the Health Department of Araçatuba, SP, Brazil, during the period from 2000 to 2017, the present study aimed at evaluating the adhesion of the students to the rabies PEPr, the protection conferred by it and the dynamics of the neutralizing IgG antibodies against rabies virus. A total of 2,404 records were evaluated, 86.4% of which presented protective titers against rabies (≥0.5 IU/mL). PEPr had good adhesion by the students, has proved to be effective for generating an... (Complete abstract click electronic access below)
Mestre
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Moore, Brandon James. "Becoming PrEPared: How Stigma and Resources Influence PrEP Uptake among Gay and Bisexual Men." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1562776093484791.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Brandão, Roberto Rubem da Silva. "Profilaxia Pré-Exposição ao HIV (PrEP) no contexto do processo de individualização e saúde." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/6/6143/tde-15062018-135509/.

Повний текст джерела
Анотація:
A Profilaxia Pré-exposição ao HIV (PrEP) é uma nova estratégia de prevenção na qual os indivíduos consomem uma combinação de antirretrovirais diariamente para evitar a aquisição do vírus da AIDS. O objetivo deste estudo foi compreender, a partir da experiência dos usuários de PrEP, a produção do processo de individualização e saúde. Analisou-se o conteúdo de discussões de um grupo de usuários de PrEP, e de pessoas interessadas no assunto, numa rede social virtual com predominância de gays, bissexuais e outros homens que fazem sexo com homens. Os resultados e discussão foram distribuídos em três artigos científicos: o primeiro, discute os conflitos da experiência dos usuários no contexto da sociedade do risco e da individualização. O segundo explora a produção das dimensões do desejo e do prazer sexual - mediados pela PrEP - na vida dos indivíduos. O terceiro, aproxima e discute a experiência dos usuários de PrEP com processos identitários autoproduzidos na individualização contemporânea. As considerações finais, por fim, refletem sobre as implicações às repostas sociais e políticas à epidemia de HIV/AIDS no atual contexto de quimioprofilaxias.
HIV Pre-exposure Prophylaxis (PrEP) is a new prevention strategy in which individuals take a daily combination of antiretrovirals in order to prevent acquiring HIV. This study aimed to understand, grounded in PrEP users\' experiences, the production of the individualization process and health. We conducted a discussion-content-analysis of PrEP users, and of interested persons on the subject, in a digital social network. Gays, bisexuals and other Men who have sex with Men accounted for the majority of the group members. Results and discussion were presented in three scientific articles: the first discusses conflicts from the experience of PrEP users in the context of risk society and individualization. The second explores productions of sexual desire and sexual pleasure - mediated by PrEP - on individuals\' lives. The third approaches and discusses PrEP users experiences and self-produced identity processes in contemporary individualization. Final remarks reflects on the implications for social and political responses to the HIV / AIDS epidemic given the current context of chemoprophylaxis.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Pre-exposure prophylaxy"

1

Chilufya, Chitalu. Implementation framework & guidance for pre-exposure prophylaxis of HIV infection. [Lusaka, Zambia]: Ministry of Health, 2018.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Davis, Suzanne Robinson. Motivations to either accept or reject pre-exposure prophylaxis: Awareness, beliefs, and risk perceptions among African American women in New York City. [New York, N.Y.?]: [publisher not identified], 2018.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Abraham, Bisrat K., Inti Flores, and Roy M. Gulick. Routine Testing for HIV Infection and Pre-Exposure and Post-Exposure Prophylaxis. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0031.

Повний текст джерела
Анотація:
Substantial progress has been made in the fight against HIV/AIDS, and newer therapies are enabling individuals to live longer and healthier lives. Furthermore, the concept of treatment as prevention is now well solidified and has increased the urgency to identify and treat all HIV-infected individuals. As such, revised guidelines for HIV testing have shifted from a model of “targeted testing” to a more universal approach whereby all individuals have routine testing for HIV as part of medical care. Despite this approach, the number of incident HIV cases has remained stable in the United States. In addition to behavioral interventions and counseling, preventative strategies such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are being used to help protect at-risk individuals.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Von Kleist, Max, Peter L. Anderson, Gerardo Garcia-Lerma, and Albert Liu, eds. Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV. Frontiers Media SA, 2020. http://dx.doi.org/10.3389/978-2-88966-096-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Pre-Exposure Prophylaxis for the Prevention of HIV Infection in Australia - 2016. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Obodo, Leonard. Men Who Have Sex with Men: Personality Attributes, Pre-Exposure Prophylaxis , and Sexual Behavior. Independently Published, 2017.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Terry-Smith, Justin. Factors Influencing Use of Pre-Exposure Prophylaxis: Among Men Who Have Sex with Men. Lulu Press, Inc., 2020.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Spicer, Shane S. HIV Psychiatry. Edited by Hunter L. McQuistion. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190610999.003.0022.

Повний текст джерела
Анотація:
Years after effective medications have been available for HIV infection, the stigma of this illness persists and presents a barrier to prevention, testing, and treatment. The treatment of HIV among people with mental illnesses is additionally challenging due to neuropsychiatric manifestations of HIV and drug interactions that may occur between antiretroviral and psychotropic medications. This chapter uses a case example to illustrate the range of psychosocial and clinical issues experienced by people living with HIV/AIDS and those at high risk of HIV infection. The chapter also provides an overview of HIV post-exposure prophylaxis and pre-exposure prophylaxis. In addition, the chapter suggests approaches for improving individual clinical care and provides recommendations for organizational and public health strategies to improve treatment and outcomes in this population.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Chu, Carolyn, and Christopher M. Bositis. HIV Transmission Prevention. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0004.

Повний текст джерела
Анотація:
The prevention of HIV transmission involves a number of behavioral, structural, and biomedical interventions. Behavioral methods include education about sexual health, drug use, and risk reduction, as well as specific messages for at-risk populations who are HIV positive. Needle exchange programs and consistent use of condoms have proven effective for prevention of HIV infection. Post-exposure prophylaxis against HIV with antiviral drugs is often recommended in occupational health care and non-occupational settings. Voluntary male circumcision also reduces the risk of HIV acquisition. The treatment of pregnant women who are HIV infected can effectively eliminate mother-to-child transmission of the virus. Recently, the use of antiretroviral drugs for pre-exposure prophylaxis has proven highly effective in preventing HIV infections in high-risk groups including men who have sex with men. Promising therapies that likely will be available in the future include injectable antiviral drugs, vaginal microbicides, and HIV vaccines.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Greaves, Ian, and Paul Hunt. Biological Incidents. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199238088.003.0009.

Повний текст джерела
Анотація:
Chapter 9 covers information on recognition of a biological incident, natural disease outbreaks, accidental release of pathogenic organisms, bioterrorism incidents, features of an intentional biological agent release, recognition of an intentional biological agent release, bioterrorism surveillance, and biological agent biodromes, initial management of a suspected biological agent release incident, general incident management principles, universal (standard) precautions, personal protective equipment, decontamination at scene, biological agent transmissibility and public health impact, mathematical models of infection spread, pre- and post-exposure prophylaxis, the hospital response to a biological incident, primary care, cardinal signs and tips for key biological agents, the role of hospital clinicians, and the unidentified biological agent and ‘white powder’ incidents.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Pre-exposure prophylaxy"

1

Liegler, Teri, and Robert Grant. "HIV-1 Drug Resistance in Pre-exposure Prophylaxis Trials." In Handbook of Antimicrobial Resistance, 479–98. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-0694-9_24.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Abdool Karim, Salim S., and Cheryl Baxter. "Translating Pre-Exposure Prophylaxis Evidence into Practice and Public Health Impact." In Biomedical Advances in HIV Prevention, 29–40. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8845-3_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Carnes, Neal A., John Malone, and Jordan Helms. "HIV Prevention: Treatment as Prevention (TasP), Occupational Postexposure Prophylaxis (oPEP), Nonoccupational Postexposure Prophylaxis (nPEP), and Pre-exposure Prophylaxis (PrEP)." In HIV/AIDS in Rural Communities, 59–71. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56239-1_5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Warrell, M. J. "Intradermal Rabies Vaccination: The Evolution and Future of Pre- and Post-exposure Prophylaxis." In Intradermal Immunization, 139–57. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/82_2010_121.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Recuenco, Sergio E. "Rabies Vaccines, Prophylactic, Peru: Massive Rabies Pre-exposure Prophylaxis for High-Risk Populations." In Rabies and Rabies Vaccines, 83–101. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-21084-7_5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Narayan, Prakash, and Kunwer Singh Mathur. "Modeling the impact of pre-exposure prophylaxis and male circumcision on HIV/AIDS." In Advances in Mathematical and Computational Modeling of Engineering Systems, 59–81. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003367420-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Dale, Renee, Yingqing Chen, and Hongyu He. "Hierarchical Modeling of the Effect of Pre-exposure Prophylaxis on HIV in the US." In Statistical Modeling in Biomedical Research, 339–54. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-33416-1_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Ribeiro, Rafaela, Bruno Sarmento, and José das Neves. "Production and Characterization of Anti-CCR5 siRNA-Loaded Polycaprolactone Nanoparticles for Topical Pre-exposure Prophylaxis." In Methods in Molecular Biology, 403–16. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1298-9_22.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Skovdal, Morten, Phyllis Magoge-Mandizvidza, Rufurwokuda Maswera, Melinda Moyo, Constance Nyamukapa, Ranjeeta Thomas, and Simon Gregson. "Stigma and Confidentiality Indiscretions: Intersecting Obstacles to the Delivery of Pre-Exposure Prophylaxis to Adolescent Girls and Young Women in East Zimbabwe." In Social Aspects of HIV, 237–48. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-69819-5_17.

Повний текст джерела
Анотація:
AbstractDespite efforts to scale-up biomedical HIV prevention technologies, such as oral pre-exposure prophylaxis (PrEP), many countries and regions of the world are far off–track in reaching global HIV prevention targets. Uptake of, and adherence to PrEP amongst adolescent girls and young women (AGYW) in sub-Saharan Africa has proved particularly challenging. Drawing on qualitative individual interviews and focus group discussions with thirty AGYW in east Zimbabwe, as well as interviews with healthcare providers, we investigate some of the root causes of this challenge, namely the social risks involved with accessing PrEP. We find that stigma and the worry of AGYW that privacy and confidentiality cannot be maintained in local health clinics and by local healthcare providers, presents a major barrier to the uptake of PrEP. We call for interventions that recognise the need to tackle the range of socio-cultural norms and social practices that interact and in synergy make engagement with PrEP an (im)possible and (un)desirable thing to do for AGYW.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Rosengarten, Marsha, and Mike Michael. "HIV Pre-exposure Prophylaxis (PrEP) and the Complexities of Biomedical Prevention: Ontological Openness and the Prevention Assemblage." In HIV Treatment and Prevention Technologies in International Perspective, 167–83. London: Palgrave Macmillan UK, 2010. http://dx.doi.org/10.1057/9780230297050_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Pre-exposure prophylaxy"

1

Chenault, Kathryn, Jaylyn Waddell, and Vicki Tepper. "Pediatric Providers and Hiv Pre-exposure Prophylaxis." In Selection of Abstracts From NCE 2016. American Academy of Pediatrics, 2018. http://dx.doi.org/10.1542/peds.141.1_meetingabstract.247.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Breen, Patrick, Jane Kelly, Timothy Heckman, and Shannon Quinn. "Mining Pre-Exposure Prophylaxis Trends in Social Media." In 2016 IEEE International Conference on Data Science and Advanced Analytics (DSAA). IEEE, 2016. http://dx.doi.org/10.1109/dsaa.2016.29.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Richardson, D., K. Nichols, A. Pickering, J. Devlin, Z. Buss, C. Fitzpatrick, and F. Cresswell. "P030 HIV post-exposure prophylaxis to pre-exposure prophylaxis transitioning in men who have sex with men." In Abstracts for the STI & HIV World Congress, July 14–17 2021. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/sextrans-2021-sti.177.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Lourenço, MDS, AM Brito, A. Alcobia, and T. Mendes. "4CPS-206 Pre-exposure prophylaxis, are we doing it right?" In 28th EAHP Congress, Bordeaux, France, 20-21-22 March 2024. British Medical Journal Publishing Group, 2024. http://dx.doi.org/10.1136/ejhpharm-2024-eahp.310.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Cartner, Emma, Muhammad Ismail, and Hannah Loftus. "P24 An audit reviewing the provision of HIV pre-exposure prophylaxis." In BASHH 2022 Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/sextrans-bashh-2022.71.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

White, Scott, Francesca Mercuri, Nicole Kruger, Grant Mclachlan, Stephan Mynhardt, Hayley Mcquilten, Bruce Miller, Ruth Tal-Singer, Christophe Demaison, and Ruth Tal-Singer. "INNA-051 pre-exposure prophylaxis in a human influenza infection model." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa2823.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Tyler, Stephanie, Harry Coleman, and Achyuta Nori. "O23 Complex pre-exposure prophylaxis MDT clinic – 6 months data review." In BASHH 2023 Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/sextrans-bashh-2023.23.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Tyler, Stephanie, Harry Coleman, Asim Ali, and Achyuta Nori. "P069 The role of a specialist HIV pre-exposure prophylaxis pharmacist." In BASHH 2023 Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/sextrans-bashh-2023.108.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

SANTOS, CARLOS JEFFERSON DE MELO, and ANGELO MARCIO OLIVEIRA SANTANNA. "Operations strategies in the recruitment process pre-exposure prophylaxis to HIV." In International Joint Conference on Industrial Engineering and Operations Management. International Joint Conference on Industrial Engineering and Operations Management, 2023. http://dx.doi.org/10.14488/ijcieom2023_full_0034_37798.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Mudzviti, Tinashe, Anesu Dhliwayo, Byron Chingombe, Bernard Ngara, Tsitsi Monera-Penduka, Charles Maponga, and Gene Morse. "P862 Female sex workers and their attitude towards oral pre-exposure prophylaxis." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.903.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Pre-exposure prophylaxy"

1

Policymakers' perceptions of oral pre-exposure prophylaxis introduction in Tanzania: Findings from implementation science research. Population Council, 2017. http://dx.doi.org/10.31899/hiv6.1022.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Modeling the expected cost-effectiveness and impact of oral pre-exposure prophylaxis in Uganda and Swaziland. Population Council, 2018. http://dx.doi.org/10.31899/hiv5.1017.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Parents' and guardians' perceptions of oral pre-exposure prophylaxis introduction in Tanzania: Findings from implementation science research. Population Council, 2017. http://dx.doi.org/10.31899/hiv6.1021.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Adolescent girls and young women’s perceptions of oral pre-exposure prophylaxis introduction in Tanzania: Findings from implementation science research. Population Council, 2017. http://dx.doi.org/10.31899/hiv6.1001.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Introducing oral pre-exposure prophylaxis to adolescent girls and young women in Tanzania: Overview of findings from implementation science research. Population Council, 2017. http://dx.doi.org/10.31899/hiv6.1018.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Pre-exposure prophylaxy" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії